Trandolapril and Verapamil Hydrochloride
1 NDC across 1 manufacturer|1 Generic,0 Brand
▸ More about this market▾ Less
Trandolapril and Verapamil Hydrochloride is available as 1 NDC from 1 manufacturer (1 generic, 0 brand), with NADAC prices from $3.64 to $3.64 per EA. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
1
1G / 0B
Manufacturers
1
competing in market
Price Spread
$3.64 – $3.64
per EA
7d Activity
avg +0.0% WoW · of 1 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Glenmark Pharmaceuticals Inc., USA manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Angiotensin Converting Enzyme Inhibitor class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
1 manufacturer producing TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
TRANDOLAPRIL-VERAPAMIL ER 4-240 MG TABLET | $3.6356 per EA | — |
Frequently Asked Questions
How many Trandolapril and Verapamil Hydrochloride products are on the market?
The Trandolapril and Verapamil Hydrochloride drug market contains 1 NDC from 1 manufacturer — 1 generic and 0 brand products.
What is the price range for Trandolapril and Verapamil Hydrochloride?
NADAC reference prices for Trandolapril and Verapamil Hydrochloride range from $3.6356 to $3.6356 per EA.
Which manufacturers make Trandolapril and Verapamil Hydrochloride?
1 manufacturer lists Trandolapril and Verapamil Hydrochloride in NADAC. Ranked by number of NDCs, the largest are Glenmark Pharmaceuticals Inc., USA (1).